| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/20/1999 | CA2309947A1 Enhanced opening of abnormal brain tissue capillaries |
| 05/20/1999 | CA2309792A1 Novel signal transduction inhibitors, compositions containing them |
| 05/20/1999 | CA2309640A1 Nuclear targeting by means of bacterial proteins |
| 05/20/1999 | CA2309598A1 Preventives and remedies for diffuse lung disease |
| 05/20/1999 | CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 05/20/1999 | CA2309557A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 05/20/1999 | CA2309538A1 Neuronal uses of bone morphogenetic protein -11 |
| 05/20/1999 | CA2309383A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
| 05/20/1999 | CA2309360A1 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 05/20/1999 | CA2309335A1 Igg-binding protein from staphylococcus and nucleotide sequence encoding this protein |
| 05/20/1999 | CA2309321A1 Use of alkylated iminosugars to treat multidrug resistance |
| 05/20/1999 | CA2309317A1 Bovine milk growth factor |
| 05/20/1999 | CA2309206A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells |
| 05/20/1999 | CA2309205A1 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 05/20/1999 | CA2309117A1 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 05/20/1999 | CA2309007A1 Secreted proteins and polynucleotides encoding them |
| 05/20/1999 | CA2308779A1 Human blood bacterium |
| 05/20/1999 | CA2308768A1 125 human secreted proteins |
| 05/20/1999 | CA2308618A1 Lysozyme-analogous proteins and peptides with an anti-microbial effect, their production and use |
| 05/20/1999 | CA2308606A1 Neisserial antigens |
| 05/20/1999 | CA2308440A1 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 05/20/1999 | CA2308373A1 Interferon immunotherapy |
| 05/20/1999 | CA2305715A1 Host derived proteins binding hcv: medical, diagnostic and purification use |
| 05/20/1999 | CA2277379A1 Medicine for promoting cicatrization and containing thrombocytes |
| 05/19/1999 | EP0916730A2 FabH from Staphylococcus aureus |
| 05/19/1999 | EP0916729A2 Novel reductase |
| 05/19/1999 | EP0916728A1 Phenyl alanyl tRNA synthetase [EC 6.1.1.20] alpha subunit family, pheS (alpha), from Streptococcus pneumoniae |
| 05/19/1999 | EP0916727A2 Novel LysS |
| 05/19/1999 | EP0916726A1 Attaching substances to micro-organisms |
| 05/19/1999 | EP0916681A1 Neuropeptides originating in scorpion |
| 05/19/1999 | EP0916680A2 Lantibiotic related to Actagardine, process of preparation and use thereof |
| 05/19/1999 | EP0916679A1 Benzazepinone-N-acetic acid derivatives having a phosphonic acid group, process for their preparation and medicaments containing these compounds |
| 05/19/1999 | EP0916678A2 Method of clotting blood |
| 05/19/1999 | EP0916352A2 Use of polymers to inhibit the denaturation of absorbed proteins |
| 05/19/1999 | EP0916346A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
| 05/19/1999 | EP0916345A1 Remedies for eating disturbance |
| 05/19/1999 | EP0916336A1 Transdermal delivery system |
| 05/19/1999 | EP0915979A2 Nucleic acids, proteins, and methods of use of granulocytic erhlichia |
| 05/19/1999 | EP0915978A2 Dna immunization against chlamydia infection |
| 05/19/1999 | EP0915977A1 B. burgdorferi polypeptides expressed in vivo |
| 05/19/1999 | EP0915975A2 Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia |
| 05/19/1999 | EP0915974A1 Modified tie-2-receptor ligands |
| 05/19/1999 | EP0915973A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 05/19/1999 | EP0915971A2 Polynucleotides from human adult pbmc endocing secreted proteins |
| 05/19/1999 | EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells |
| 05/19/1999 | EP0915911A1 Parathyroid hormone analogues for the treatment of osteoporosis |
| 05/19/1999 | EP0915910A1 Exendin analogues, processes for their preparation and medicaments containing them |
| 05/19/1999 | EP0915908A1 Dolastatin pentapeptide derivatives and their use as antitumor agents |
| 05/19/1999 | EP0915904A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
| 05/19/1999 | EP0915736A1 Filter sheet and process for purifying photoresist composition employing the filter sheet |
| 05/19/1999 | EP0915710A2 Stable radioiodine conjugates and methods for their synthesis |
| 05/19/1999 | EP0915707A1 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
| 05/19/1999 | EP0915706A1 Screening methods for compounds useful in the regulation of body weight |
| 05/19/1999 | EP0915700A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 05/19/1999 | EP0915668A1 Drinkable, acid nutrient composition with long shelf life and health-promoting action |
| 05/19/1999 | EP0915648A1 Methods and compositions for the selective modification of nucleic acids |
| 05/19/1999 | EP0804456A4 Peptide nucleic acid conjugates |
| 05/19/1999 | EP0662837B1 Use of il-10 to prevent insulin-dependent diabetes mellitus |
| 05/19/1999 | EP0654968B1 Anti-microbial composition |
| 05/19/1999 | EP0607346B1 Collagen constructs |
| 05/19/1999 | EP0552257B1 A plant protein useful for treating tumors and hiv infection |
| 05/19/1999 | EP0500921B1 Na-k-atpase inhibiting natriuretic substances |
| 05/19/1999 | EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS |
| 05/19/1999 | CN1217028A Method of modulating melanin synthesis |
| 05/19/1999 | CN1217027A Parapoxviruses contg. foreign DNA, their prodn. and their use in vacciens |
| 05/19/1999 | CN1217025A Processed polypeptides with IL-16 activity, process for preparing same and their use |
| 05/19/1999 | CN1217024A Chemokine alpha 2 |
| 05/19/1999 | CN1217023A Canine OB protein compositions and method for recombinant prodn. |
| 05/19/1999 | CN1217022A Therapeutic uses of keratinocyte growth factor |
| 05/19/1999 | CN1216995A Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 05/19/1999 | CN1216994A Apoptosis inducing molecule II |
| 05/19/1999 | CN1216915A Storage stable dentifrice composition contg. casein |
| 05/19/1999 | CN1216777A Method for transferring human solid tumor Endostatin gene bifidobacteria |
| 05/19/1999 | CN1216768A Biologic antibiotic peptide, and method for preparing same |
| 05/19/1999 | CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them |
| 05/19/1999 | CN1216685A Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
| 05/18/1999 | US5905149 Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors |
| 05/18/1999 | US5905146 In general, a novel polypeptide, designated s1-3, is identified and characterized. the mrna for this protein is preferentially overexpressed in senescent human fibroblast cells or fibroblast cells derived from a patient with werner |
| 05/18/1999 | US5905145 These tumor rejection antigen precursors are referred to as ?tage? tumor rejection antigen precursors. |
| 05/18/1999 | US5905142 Protease resistant PDGF and methods of use |
| 05/18/1999 | US5905141 Ultra pure hemoglobin solutions and blood substitutes |
| 05/18/1999 | US5905140 Acylating insulin, insulin analogs, and insulin precursors on free epsilon-amino group of lysine using activated amide with acyl group in polar solvent in presence of base |
| 05/18/1999 | US5905083 Method of treating rheumatoid arthritis |
| 05/18/1999 | US5905082 Crystalline oxathiolane derivatives |
| 05/18/1999 | US5905077 Inhibitors of HIV protease useful for the treatment of AIDS |
| 05/18/1999 | US5905076 Treatment of muscular dystrophy, arthritis, myocardial infarction, alzheimer's disease, bacterial infection, common cold, osteoporosis or cancer metastasis |
| 05/18/1999 | US5905071 Glycosylamides of 2-aminoacylamino-2-deoxy sugars |
| 05/18/1999 | US5905070 5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides |
| 05/18/1999 | US5905027 Identifying neoplastic brain tissues based on binding affinty of antibodiesto antigens of chloride channels |
| 05/18/1999 | US5905023 Maspin, a serpin with tumor suppressing activity |
| 05/18/1999 | US5904938 Anticoagulants using nitric oxide by breathing |
| 05/18/1999 | US5904935 Delivery of drugs with peptides and proteins |
| 05/18/1999 | US5904922 Purified chicken antivenom in aqueous solution |
| 05/18/1999 | US5904921 Stabilized compositions of superoxide dismutase obtained from germinated plant seeds |
| 05/18/1999 | US5904920 Regulation of systemic immune responses utilizing cytokines and antigens |
| 05/18/1999 | US5904716 Method for reconstituting cartilage tissue using demineralized bone and product thereof |
| 05/18/1999 | US5904144 Method for delivering a biologically active molecule to the eye |
| 05/18/1999 | CA1340548C Method for producing native hiv gp160 |
| 05/18/1999 | CA1340547C Novel secretory leader sequences for yeasts |
| 05/18/1999 | CA1340544C Human tissue factor related dna segments, polypeptides and antibodies |